Recombinant human serum albumin-interferon alpha fusion protein - Hangzhou Jiuyuan Gene EngineeringAlternative Names: rHSA-IFNα2b
Latest Information Update: 18 Feb 2016
At a glance
- Originator Hangzhou Jiuyuan Gene Engineering
- Class Recombinant fusion proteins
- Mechanism of Action Immunostimulants; Interferon alpha 2b stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Hepatitis B; Hepatitis C
Most Recent Events
- 18 Feb 2016 Investigation in Hepatitis C in China (Parenteral)
- 18 Feb 2016 Investigation in Hepatitis B in China (Parenteral)